Alcon Inc.(0A0D)
USD --+0.00%
Reward66High
Risk34Moderate
📊75%Data
0A0D
+0.0 · +0.00%
USD · LSE
Alcon Inc. |
Quality Compounder
Market Cap:
ℹ️
Reward Rating
66
High
Top 25% (model universe)
75% data coverage
ℹ️
Risk Rating
34
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on 0A0D to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Alcon Inc.?

researches, develops, manufactures, distributes, and sells eye care products worldwide.

0A0D · Verdict

Solid reward · moderate risk

0A0D scores well on growth and cash flow with no major weaknesses flagged in the model.

Based on 88% data coverage

0A0D · Verdict

What’s working & what to watch

Strengths 5

  • Growth76/100

    Rev +6.1% CAGR · earnings +39.4%

  • Cash flow76/100

    16% free-cash-flow margin

  • Balance sheet71/100

    Interest covered 9.2×

  • Profitability68/100

    10% net margin · 5% ROE

  • Volatility65/100

    Above average

No major weaknesses flagged.

Model-based scoring. For information only — not financial advice.

What is Alcon Inc.?

researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. The company is listed on the LSE in UK, and a P/E ratio of 0.8x.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Adequate profitability with some margin variability in recent periods.
⚠️ Risk
Below-average volatility supports a steadier risk profile.
💸 Valuation
Valuation appears fair relative to current fundamentals.

OpenBook Logo Analysis

Reward: High (66)

The scoring profile indicates moderate reward potential, with growth and profitability as the leading contributors. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorN/A
Market CapN/A
P/E Ratio0.7875
Dividend Yield0.49%
52 Week High86.94
52 Week Low56.46
Last AnnualDecember
IPO DateN/A
IncorporatedUK
Shares Outstanding302M
No. of Employees25,942
IndustryN/A
ExchangeLSE
Beta0.737
CurrencyUSD